We are live on ! Find out more
MCM

McGlinn Capital Management Portfolio holdings

AUM $33.1M
1-Year Est. Return 37.58%
This Fund
S&P 500
This Quarter Est. Return
-6.12%
1 Year Est. Return
-37.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$48M
AUM Growth
+$3.92M
Cap. Flow
+$5.6M
Cap. Flow %
11.67%
Top 10 Hldgs %
45.94%
Holding
71
New
14
Increased
8
Reduced
22
Closed
13

Top Buys

Rank Stock Value
1
FAZ
Direxion Daily Financial Bear 3x ETF
FAZ
+$2.16M
2
ONIT
Onity Group
ONIT
+$1.9M
3
NUS icon
Nu Skin
NUS
+$1.84M
4
WAC
Walter Investment Mgt Corp
WAC
+$1.38M
5
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
+$1.23M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.45M
2
DLR icon
Digital Realty Trust
DLR
+$1.3M
3
EMC
EMC CORPORATION
EMC
+$803K
4
MS icon
Morgan Stanley
MS
+$618K
5
PFE icon
Pfizer
PFE
+$438K

Sector Composition

Rank Sector Weight
1 Financials 24.55%
2 Real Estate 12.96%
3 Technology 12.45%
4 Consumer Staples 5.02%
5 Energy 4.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLV
51
DELISTED
CLIFFS NAT RES INC. DEPO SHS REPSTG 1/40TH PFD CONV SER A
CLV
$135K 0.28%
6,500
– –
RSG icon
52
Republic Services
RSG
$64.5B
$113K 0.24%
+3,300
New +$110K
PSEC icon
53
Prospect Capital
PSEC
$1.11B
$108K 0.23%
+10,000
New +$111K
JAKK icon
54
Jakks Pacific
JAKK
$292M
$71K 0.15%
980
-150
-13% -$9.83K
MFIN icon
55
Medallion Financial
MFIN
$250M
$59K 0.12%
4,500
– –
AVP
56
DELISTED
Avon Products, Inc.
AVP
$10K 0.02%
700
– –
GS.PRB.CL
57
DELISTED
Goldman Sachs Group Depositary Shares (1/1000 Interest of 6.2% Non-Cum. Prfrd. Stock, Series B) Call
GS.PRB.CL
$10K 0.02%
400
– –
AA icon
58
Alcoa
AA
$12.5B
– –
-6,617
Closed -$169K
DOC icon
59
Healthpeak Properties
DOC
$14.5B
– –
-2,196
Closed -$73K
GDX icon
60
VanEck Gold Miners ETF
GDX
$25.6B
– –
-20,000
Closed -$423K
MRK icon
61
Merck
MRK
$317B
– –
-6,183
Closed -$295K
NBR icon
62
Nabors Industries
NBR
$1.23B
– –
-464
Closed -$394K
PFE icon
63
Pfizer
PFE
$149B
– –
-15,072
Closed -$438K
SUPN icon
64
Supernus Pharmaceuticals
SUPN
$2.72B
– –
-30,300
Closed -$228K
UAL icon
65
United Airlines
UAL
$41.9B
– –
-4,500
Closed -$170K
XYL icon
66
Xylem
XYL
$28.2B
– –
-6,800
Closed -$235K
MXIM
67
DELISTED
Maxim Integrated Products
MXIM
– –
-10,000
Closed -$279K
BRCM
68
DELISTED
BROADCOM CORP CL-A
BRCM
– –
-2,400
Closed -$71K
MTB.PRA
69
DELISTED
M &T Cap Tr IV Gtd Enhanced Tr Pfd Secs 12/31/2068
MTB.PRA
– –
-300
Closed -$8K
1 2
3

Similar funds

ACMM
American Capital Mortgage Management Bethesda, Maryland $33.9M AUM 13.41% 1-Year Est. Return
MXM
Mayfield XII Management Menlo Park, California $32.1M AUM 23.87% 1-Year Est. Return
AIC
Atlantic Investment Company Atlanta, Georgia $34.3M AUM 10.7% 1-Year Est. Return
AC
Andromeda Capital White Plains, New York $31.8M AUM 52.44% 1-Year Est. Return
SM
SCFF Management Menlo Park, California $31.6M AUM 0.5% 1-Year Est. Return
BCM
Brightfield Capital Management New York $31.2M AUM 3.22% 1-Year Est. Return
WAM
Wavelength Asset Management New York $31M AUM 22.57% 1-Year Est. Return
SCM
Seamans Capital Management Boston, Massachusetts $30.2M AUM 15.76% 1-Year Est. Return

McGlinn Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, McGlinn Capital Management held 71 positions worth $48M, up 8.9% from $44M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

McGlinn Capital Management deployed $5.6M of net new capital in Q1 2014, opening 14 new positions and adding to 8 existing holdings. Its largest new stake was Direxion Daily Financial Bear 3x ETF: 63 shares worth $1.95M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 19% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was Eli Lilly, an estimated $1.45M trimmed.

  • McGlinn Capital Management's largest Q1 2014 buy was Direxion Daily Financial Bear 3x ETF: 63 shares worth $1.95M.
  • McGlinn Capital Management added most to iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2014, an estimated $1.23M increase.
  • McGlinn Capital Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $1.45M.
  • McGlinn Capital Management fully exited Pfizer in Q1 2014, selling an estimated $438K.
  • McGlinn Capital Management's ten largest holdings make up 46% of its $48M portfolio in Q1 2014.
  • McGlinn Capital Management opened 14 new positions and closed 13 in Q1 2014.
  • McGlinn Capital Management's portfolio value rose 8.9% quarter-over-quarter to $48M.

Based on McGlinn Capital Management's 13F filing for Q1 2014, filed 9 May 2014.